Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
74
IHE Quote, Financials, Valuation and Earnings
Last price:
$84.92
Seasonality move
:
1.25%
Day range:
$84.30 - $85.39
52-week range:
$58.97 - $86.28
Dividend yield:
1.76%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
75.7K
Avg. volume:
116.1K
1-year change:
30.48%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IAT
iShares US Regional Banks ETF
|
-- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- |
|
IYG
iShares US Financial Services ETF
|
-- | -- | -- | -- | -- |
|
IYT
iShares US Transportation ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
$85.01 | -- | -- | -- | $0.59 | 1.76% | -- |
|
IAT
iShares US Regional Banks ETF
|
$56.01 | -- | -- | -- | $0.58 | 2.9% | -- |
|
IHF
iShares US Healthcare Providers ETF
|
$47.78 | -- | -- | -- | $0.22 | 1.05% | -- |
|
IHI
iShares US Medical Devices ETF
|
$62.63 | -- | -- | -- | $0.06 | 0.34% | -- |
|
IYG
iShares US Financial Services ETF
|
$92.13 | -- | -- | -- | $0.26 | 1% | -- |
|
IYT
iShares US Transportation ETF
|
$75.03 | -- | -- | -- | $0.15 | 1% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | 0.266 | -- | -- |
|
IAT
iShares US Regional Banks ETF
|
-- | 1.676 | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | 0.644 | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | 0.868 | -- | -- |
|
IYG
iShares US Financial Services ETF
|
-- | 1.175 | -- | -- |
|
IYT
iShares US Transportation ETF
|
-- | 1.602 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IAT
iShares US Regional Banks ETF
|
-- | -- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- | -- |
|
IYG
iShares US Financial Services ETF
|
-- | -- | -- | -- | -- | -- |
|
IYT
iShares US Transportation ETF
|
-- | -- | -- | -- | -- | -- |
iShares US Pharmaceuticals ETF vs. Competitors
-
Which has Higher Returns IHE or IAT?
iShares US Regional Banks ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Regional Banks ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IATiShares US Regional Banks ETF-- -- -- -
What do Analysts Say About IHE or IAT?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Regional Banks ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Regional Banks ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Regional Banks ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IATiShares US Regional Banks ETF0 0 0 -
Is IHE or IAT More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.559, which suggesting that the stock is 44.141% less volatile than S&P 500. In comparison iShares US Regional Banks ETF has a beta of 1.070, suggesting its more volatile than the S&P 500 by 6.983%.
-
Which is a Better Dividend Stock IHE or IAT?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.59 per share corresponding to a yield of 1.76%. iShares US Regional Banks ETF offers a yield of 2.9% to investors and pays a quarterly dividend of $0.58 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Regional Banks ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IAT?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Regional Banks ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Regional Banks ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Regional Banks ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Regional Banks ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IATiShares US Regional Banks ETF-- -- -- --
-
Which has Higher Returns IHE or IHF?
iShares US Healthcare Providers ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IHFiShares US Healthcare Providers ETF-- -- -- -
What do Analysts Say About IHE or IHF?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Healthcare Providers ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Healthcare Providers ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IHFiShares US Healthcare Providers ETF0 0 0 -
Is IHE or IHF More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.559, which suggesting that the stock is 44.141% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.731, suggesting its less volatile than the S&P 500 by 26.927%.
-
Which is a Better Dividend Stock IHE or IHF?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.59 per share corresponding to a yield of 1.76%. iShares US Healthcare Providers ETF offers a yield of 1.05% to investors and pays a quarterly dividend of $0.22 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IHF?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IHFiShares US Healthcare Providers ETF-- -- -- --
-
Which has Higher Returns IHE or IHI?
iShares US Medical Devices ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Medical Devices ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IHIiShares US Medical Devices ETF-- -- -- -
What do Analysts Say About IHE or IHI?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Medical Devices ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Medical Devices ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Medical Devices ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IHIiShares US Medical Devices ETF0 0 0 -
Is IHE or IHI More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.559, which suggesting that the stock is 44.141% less volatile than S&P 500. In comparison iShares US Medical Devices ETF has a beta of 1.010, suggesting its more volatile than the S&P 500 by 1.009%.
-
Which is a Better Dividend Stock IHE or IHI?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.59 per share corresponding to a yield of 1.76%. iShares US Medical Devices ETF offers a yield of 0.34% to investors and pays a quarterly dividend of $0.06 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Medical Devices ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IHI?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Medical Devices ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Medical Devices ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Medical Devices ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Medical Devices ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IHIiShares US Medical Devices ETF-- -- -- --
-
Which has Higher Returns IHE or IYG?
iShares US Financial Services ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Financial Services ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IYGiShares US Financial Services ETF-- -- -- -
What do Analysts Say About IHE or IYG?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Financial Services ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Financial Services ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Financial Services ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IYGiShares US Financial Services ETF0 0 0 -
Is IHE or IYG More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.559, which suggesting that the stock is 44.141% less volatile than S&P 500. In comparison iShares US Financial Services ETF has a beta of 1.143, suggesting its more volatile than the S&P 500 by 14.331%.
-
Which is a Better Dividend Stock IHE or IYG?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.59 per share corresponding to a yield of 1.76%. iShares US Financial Services ETF offers a yield of 1% to investors and pays a quarterly dividend of $0.26 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Financial Services ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IYG?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Financial Services ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Financial Services ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Financial Services ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Financial Services ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IYGiShares US Financial Services ETF-- -- -- --
-
Which has Higher Returns IHE or IYT?
iShares US Transportation ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Transportation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IYTiShares US Transportation ETF-- -- -- -
What do Analysts Say About IHE or IYT?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Transportation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Transportation ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Transportation ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IYTiShares US Transportation ETF0 0 0 -
Is IHE or IYT More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.559, which suggesting that the stock is 44.141% less volatile than S&P 500. In comparison iShares US Transportation ETF has a beta of 1.318, suggesting its more volatile than the S&P 500 by 31.816%.
-
Which is a Better Dividend Stock IHE or IYT?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.59 per share corresponding to a yield of 1.76%. iShares US Transportation ETF offers a yield of 1% to investors and pays a quarterly dividend of $0.15 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Transportation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IYT?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Transportation ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Transportation ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Transportation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Transportation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IYTiShares US Transportation ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
